Liberal versus restrictive blood transfusion strategy: 3-year survival and cause of death results from the FOCUS randomised controlled trial by Carson, Jeffrey L, Prof, Sieber, Frederick, Prof, Cook, Donald Richard, MD, Hoover, Donald R, Prof, Noveck, Helaine, MPH, Chaitman, Bernard R, Prof, Fleisher, Lee, Prof, Beaupre, Lauren, PhD, Macaulay, William, Prof, Rhoads, George G, Prof, Paris, Barbara, MD, Zagorin, Aleksandra, DNP, Sanders, David W, MD, Zakriya, Khwaja J, MD, Magaziner, Jay, Prof

Get full text

Global respiratory syncytial virus-associated mortality in young children (RSV GOLD): a retrospective case series by Scheltema, Nienke M, Gentile, Angela, Lucion, Florencia, Nokes, D James, Munywoki, Patrick K, Madhi, Shabir A, Groome, Michelle J, Cohen, Cheryl, Moyes, Jocelyn, Thorburn, Kentigern, Thamthitiwat, Somsak, Oshitani, Hitoshi, Lupisan, Socorro P, Gordon, Aubree, Sánchez, José F, O'Brien, Katherine L, Gessner, Bradford D, Sutanto, Agustinus, Mejias, Asuncion, Ramilo, Octavio, Khuri-Bulos, Najwa, Halasa, Natasha, de-Paris, Fernanda, Pires, Márcia Rosane, Spaeder, Michael C, Paes, Bosco A, Simões, Eric A F, Leung, Ting F, da Costa Oliveira, Maria Tereza, de Freitas Lázaro Emediato, Carla Cecília, Bassat, Quique, Butt, Warwick, Chi, Hsin, Aamir, Uzma Bashir, Ali, Asad, Lucero, Marilla G, Fasce, Rodrigo A, Lopez, Olga, Rath, Barbara A, Polack, Fernando P, Papenburg, Jesse, Roglić, Srđan, Ito, Hisato, Goka, Edward A, Grobbee, Diederick E, Nair, Harish, Bont, Louis J

Get full text

A New Subcutaneous Immunoglobulin 20% Formulation (SCIG 20%) with Individualized Infusion Parameters Resulted in a Positive Safety and Tolerability Profile in Patients with PIDD in... by Suez, Daniel, MD, FAAAAI, Krivan, Gregely, PhD, Jolles, Stephen R., MD, Hussain, Iftikhar, Stein, Mark R., MD, FAAAAI, Gupta, Sudhir, MD, Ph.D, MACP, Paris, Kenneth, MD, MPH, van Hagen, Martin, Brodszki, Nicholas, MD, PhD, McCoy, Barbara, PhD, Yel, Leman, MD FAAAAI

Get full text

Analysis of Safety and Tolerability Data in Pediatric Patients with Primary Immunodeficiency Diseases from Two Phase 2/3 Studies of Human Immune Globulin Subcutaneous, 20 by Paris, Kenneth, MD, MPH, Haddad, Elie, MD, PhD, Hussain, Iftikhar, Brodszki, Nicholas, MD, PhD, Darter, Amy Liebl, MD, FAAAAI, Engl, Werner, PhD, McCoy, Barbara, PhD, Yel, Leman, MD, FAAAAI

Get full text

Efficacy, Safety, Tolerability, and Pharmacokinetics of Human Immune Globulin Subcutaneous, 20% (IGSC 20%): Final Analysis of a Phase 2/3 Study in Patients with Primary Immunodefic... by Suez, Daniel, MD, FAAAAI, Melamed, Isaac, MD, Hussain, Iftikhar, MD, FAAAAI, Stein, Mark R., MD, FAAAAI, Gupta, Sudhir, MD, PhD, FAAAAI, Paris, Kenneth, MD, MPH, Fritsch, Sandor, PhD, Bourgeois, Christelle, PhD, Leibl, Heinz, PhD, McCoy, Barbara, PhD, Yel, Leman, MD, FAAAAI

Get full text

Review of the Onboarding Experience of a New 20% Human Immune Globulin for Subcutaneous Administration (SCIG 20%): Correlation of Infusion Parameters and Adverse Events (AEs) by Gupta, Sudhir, MD, PhD, MACP, Stein, Mark R., MD, FAAAAI, Melamed, Isaac Reuven, MD, Hussain, Iftikhar, Paris, Kenneth, MD, MPH, Engl, Werner, PhD, McCoy, Barbara, PhD, Rabbat, Christopher J., PhD, Yel, Leman, MD, FAAAAI

Get full text

An efficient synthetic route to l-γ-methyleneglutamine and its amide derivatives, and their selective anticancer activity by Hossain, Md Imran, Thomas, Ajit G, Mahdi, Fakhri, Adam, Amna T, Akins, Nicholas S, Woodard, Morgan M, Paris, Jason J, Slusher, Barbara S, Le, Hoang V

Get full text

An efficient synthetic route to -γ-methyleneglutamine and its amide derivatives, and their selective anticancer activity by Hossain, Md Imran, Thomas, Ajit G, Mahdi, Fakhri, Adam, Amna T, Akins, Nicholas S, Woodard, Morgan M, Paris, Jason J, Slusher, Barbara S, Le, Hoang V

Get full text